应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AMLX Amylyx Pharmaceuticals, Inc.
交易中 03-28 12:22:08 EDT
2.97
+0.09
+2.95%
最高
2.97
最低
2.83
成交量
74.21万
今开
2.86
昨收
2.88
日振幅
4.86%
总市值
2.01亿
流通市值
1.51亿
总股本
6,778万
成交额
215.02万
换手率
1.46%
流通股本
5,094万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.07%报2.88美元
自选股智能写手 · 03-27 22:32
Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.07%报2.88美元
Amylyx Pharmaceuticals, Inc.盘中异动 大幅下跌5.23%
自选股智能写手 · 03-23
Amylyx Pharmaceuticals, Inc.盘中异动 大幅下跌5.23%
Amylyx Pharmaceuticals, Inc.盘中异动 快速下挫5.56%
自选股智能写手 · 03-18
Amylyx Pharmaceuticals, Inc.盘中异动 快速下挫5.56%
Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.27%
自选股智能写手 · 03-14
Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.27%
Amylyx Pharmaceuticals, Inc.盘中异动 急速下跌5.26%报3.60美元
自选股智能写手 · 03-12
Amylyx Pharmaceuticals, Inc.盘中异动 急速下跌5.26%报3.60美元
BUZZ-ALS 药物在关键研究中失败后,分析师下调了 Amylyx 的股票评级,导致其股价下跌
Reuters · 03-12
BUZZ-ALS 药物在关键研究中失败后,分析师下调了 Amylyx 的股票评级,导致其股价下跌
Amylyx Pharmaceuticals, Inc.盘中异动 快速上涨5.06%
自选股智能写手 · 03-11
Amylyx Pharmaceuticals, Inc.盘中异动 快速上涨5.06%
嗡嗡声--美国股票走势-通用电气、Ainos、Velo3D
Reuters · 03-08
嗡嗡声--美国股票走势-通用电气、Ainos、Velo3D
BUZZ-已获批准的 ALS 药物在确证研究中失败后,Amylyx 下跌
Reuters · 03-08
BUZZ-已获批准的 ALS 药物在确证研究中失败后,Amylyx 下跌
Amylyx公司的ALS药物在晚期确证研究中失败
Reuters · 03-08
Amylyx公司的ALS药物在晚期确证研究中失败
Amylyx Pharmaceuticals Inc盘中异动 大幅上涨5.15%报18.56美元
自选股智能写手 · 02-26
Amylyx Pharmaceuticals Inc盘中异动 大幅上涨5.15%报18.56美元
Amylyx Pharmaceuticals Inc2023财年实现净利润49.27百万美元,同比增加124.88%
自选股智能写手 · 02-26
Amylyx Pharmaceuticals Inc2023财年实现净利润49.27百万美元,同比增加124.88%
嗡嗡声--美国股票走势-Wayfair Inc、Remitly Global、Monopar Therapeutics
Reuters · 02-22
嗡嗡声--美国股票走势-Wayfair Inc、Remitly Global、Monopar Therapeutics
Amylyx Pharmaceuticals Inc盘中异动 大幅拉升8.10%
自选股智能写手 · 02-22
Amylyx Pharmaceuticals Inc盘中异动 大幅拉升8.10%
BUZZ-Amylyx 因第四季度收入增加而上涨
Reuters · 02-22
BUZZ-Amylyx 因第四季度收入增加而上涨
加载更多
公司概况
公司名称:
Amylyx Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Amylyx Pharmaceuticals, Inc.于2014年1月10日根据特拉华州法律成立。他们的任务是开发治疗方法,通过让神经元存活来改变肌萎缩侧索硬化症和一系列神经退行性疾病的治疗模式。该公司正在寻求其候选产品AMX0035的商业化,他们认为这是第一个在ALS患者的大规模临床试验中显示出功能和生存益处的候选药物。该公司相信AMX0035有潜力成为一种基础疗法,这意味着它可以单独使用或与其他疗法结合使用,以改变广泛的神经退行性疾病的治疗模式。
发行价格:
--
{"stockData":{"symbol":"AMLX","market":"US","secType":"STK","nameCN":"Amylyx Pharmaceuticals, Inc.","latestPrice":2.965,"timestamp":1711642923652,"preClose":2.88,"halted":0,"volume":742139,"delay":0,"floatShares":50937992,"shares":67782139,"eps":0.7,"marketStatus":"交易中","marketStatusCode":2,"change":0.085,"latestTime":"03-28 12:22:08 EDT","open":2.86,"high":2.97,"low":2.83,"amount":2150192.4228073,"amplitude":0.048611,"askPrice":2.97,"askSize":171,"bidPrice":2.96,"bidSize":2100,"shortable":3,"etf":0,"ttmEps":0.7,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1711656000000},"adr":0,"listingDate":1641531600000,"adjPreClose":2.88,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.879,"preClose":2.88,"latestTime":"09:28 EDT","volume":3944,"amount":11270.141704,"timestamp":1711632484718},"postHourTrading":{"tag":"盘后","latestPrice":2.8599,"preClose":2.88,"latestTime":"19:30 EDT","volume":98924,"amount":284840.7587,"timestamp":1711582259334},"volumeRatio":0.762279},"requestUrl":"/m/hq/s/AMLX?invite=TIGER026","defaultTab":"news","newsList":[{"id":"2422158609","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.07%报2.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422158609","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422158609?lang=zh_cn&edition=full","pubTime":"2024-03-27 22:32","pubTimestamp":1711549960,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日22时32分,Amylyx Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.07%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.57%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272232407a4f8aac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272232407a4f8aac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421824470","title":"Amylyx Pharmaceuticals, Inc.盘中异动 大幅下跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421824470","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421824470?lang=zh_cn&edition=full","pubTime":"2024-03-23 03:55","pubTimestamp":1711137345,"startTime":"0","endTime":"0","summary":"北京时间2024年03月23日03时55分,Amylyx Pharmaceuticals, Inc.股票出现波动,股价快速下挫5.23%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240323035545861e080f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240323035545861e080f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420747489","title":"Amylyx Pharmaceuticals, Inc.盘中异动 快速下挫5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420747489","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420747489?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:34","pubTimestamp":1710768864,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时34分,Amylyx Pharmaceuticals, Inc.股票出现异动,股价急速跳水5.56%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.14%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213424791b34fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213424791b34fd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419607615","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419607615","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419607615?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:39","pubTimestamp":1710423578,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时39分,Amylyx Pharmaceuticals, Inc.股票出现异动,股价大幅下挫5.27%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314213939861de3c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314213939861de3c8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418537494","title":"Amylyx Pharmaceuticals, Inc.盘中异动 急速下跌5.26%报3.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418537494","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418537494?lang=zh_cn&edition=full","pubTime":"2024-03-12 21:32","pubTimestamp":1710250331,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日21时32分,Amylyx Pharmaceuticals, Inc.股票出现波动,股价快速下跌5.26%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。其相关个股中,Regulus Therapeutics Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Tc Biopharm Plc涨幅较大,Regulus Therapeutics Inc.、Scisparc Ltd.、Tc Biopharm Plc较为活跃,换手率分别为150.20%、127.39%、27.47%,振幅较大的相关个股有Regulus Therapeutics Inc.、Scorpius Holdings, Inc.、Aslan Pharmaceuticals Limited,振幅分别为34.35%、13.07%、12.26%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221321187e782f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221321187e782f0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418953482","title":"BUZZ-ALS 药物在关键研究中失败后,分析师下调了 Amylyx 的股票评级,导致其股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2418953482","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2418953482?lang=zh_cn&edition=full","pubTime":"2024-03-12 21:07","pubTimestamp":1710248837,"startTime":"0","endTime":"0","summary":" 3月12日 - ** 制药商Amylyx Pharmaceuticals 股价盘前下跌5.8%至3.58美元** AMLX股价周五创下历史新低, ,此前该公司表示,由于在一项晚期试验中未能减缓疾病进展,它正在考虑从市场上撤回其肌萎缩性脊髓侧索硬化症 治疗药物Relyvrio。** 自上周五以来,至少有两家券商下调了该公司的股票评级** H.C. Wainwright 将预期评级从 42 美元下调至 8 美元** 鉴于试验结果,\"即将在第二季度 \"取消 Relyvrio 在 ALS 中的应用--券商** 截至上次收盘,股价在过去 12 个月中下跌了 87.6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2418636397","title":"Amylyx Pharmaceuticals, Inc.盘中异动 快速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418636397","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418636397?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:51","pubTimestamp":1710165096,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时51分,Amylyx Pharmaceuticals, Inc.股票出现异动,股价快速上涨5.06%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.42%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311215136861dd16c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311215136861dd16c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417905289","title":"嗡嗡声--美国股票走势-通用电气、Ainos、Velo3D","url":"https://stock-news.laohu8.com/highlight/detail?id=2417905289","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417905289?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:14","pubTimestamp":1709907283,"startTime":"0","endTime":"0","summary":" * 个股走势的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 3月8日 - 在华尔街隔夜大幅反弹之后,美国股指期货周五下滑,因为投资者在为一份可能决定利率走向的重要劳动力市场报告做准备。美东时间9:01,道指电子盘 上涨0.03%,报38837点。标准普尔500指数小型股 上涨0.27%,报5175.75点;纳斯达克100指数小型股 上涨0.26%,报18363点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417832058","title":"BUZZ-已获批准的 ALS 药物在确证研究中失败后,Amylyx 下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2417832058","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417832058?lang=zh_cn&edition=full","pubTime":"2024-03-08 20:18","pubTimestamp":1709900320,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 3月8日 - ** Amylyx制药公司 股价盘前下跌73.3%至5.05美元** 该公司称 (link),其已获批准的ALS药物(在美国名为Relyvrio,在加拿大名为Albrioza)未能达到后期确证试验的主要目标。 ** AMLX公司表示将与外界分享有关该药物的计划,其中可能包括自愿将其撤出市场** 截至上次收盘,股价在过去 12 个月中下跌了 47.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417030693","title":"Amylyx公司的ALS药物在晚期确证研究中失败","url":"https://stock-news.laohu8.com/highlight/detail?id=2417030693","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417030693?lang=zh_cn&edition=full","pubTime":"2024-03-08 20:07","pubTimestamp":1709899668,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透社3月8日 - Amylyx Pharmaceuticals 公司周五称,其治疗神经系统疾病ALS(肌萎缩性脊髓侧索硬化症)的药物未能在一项晚期确证研究中达到主要目标。 该公司说,它对这种药物的计划可能包括主动从市场上撤出。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414836499","title":"Amylyx Pharmaceuticals Inc盘中异动 大幅上涨5.15%报18.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414836499","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414836499?lang=zh_cn&edition=full","pubTime":"2024-02-26 23:06","pubTimestamp":1708960009,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日23时06分,Amylyx Pharmaceuticals Inc股票出现异动,股价快速上涨5.15%。截至发稿,该股报18.56美元/股,成交量14.3848万股,换手率0.21%,振幅5.35%。Amylyx Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为0.32%。Amylyx Pharmaceuticals Inc公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022623064987e732b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022623064987e732b5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414099255","title":"Amylyx Pharmaceuticals Inc2023财年实现净利润49.27百万美元,同比增加124.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414099255","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414099255?lang=zh_cn&edition=full","pubTime":"2024-02-26 00:25","pubTimestamp":1708878314,"startTime":"0","endTime":"0","summary":"12月31日,Amylyx Pharmaceuticals Inc公布财报,公告显示公司2023财年净利润为49.27百万美元,同比增加124.88%;其中营业收入为3.81亿美元,同比增加1613.90%,每股基本收益为0.73美元。机构评级:截至2023年12月31日,当前有7家机构对Amylyx Pharmaceuticals Inc目标价做出预测,其中目标均价为35.57美元,其中最低目标价为27.00美元,最高目标价为42.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022600251687bddb26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022600251687bddb26&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413624820","title":"嗡嗡声--美国股票走势-Wayfair Inc、Remitly Global、Monopar Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2413624820","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413624820?lang=zh_cn&edition=full","pubTime":"2024-02-22 23:55","pubTimestamp":1708617309,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 2月22日 - 在英伟达的出色业绩和预测刺激了今年人工智能引领的涨势之后,基准标普500指数周四短暂创下新纪录。美东时间10:31,道琼斯工业平均指数 上涨0.71%,报38888.1点。标准普尔500指数 上涨1.62%,报5062.63点;纳斯达克综合指数 上涨2.43%,报15959.39点。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413744211","title":"Amylyx Pharmaceuticals Inc盘中异动 大幅拉升8.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413744211","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413744211?lang=zh_cn&edition=full","pubTime":"2024-02-22 22:30","pubTimestamp":1708612223,"startTime":"0","endTime":"0","summary":"北京时间2024年02月22日22时30分,Amylyx Pharmaceuticals Inc股票出现异动,股价快速拉升8.10%。Amylyx Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为0.20%。Amylyx Pharmaceuticals Inc公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240222223023861d77b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240222223023861d77b7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413518218","title":"BUZZ-Amylyx 因第四季度收入增加而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2413518218","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413518218?lang=zh_cn&edition=full","pubTime":"2024-02-22 21:00","pubTimestamp":1708606826,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 2月22日 - ** 制药商 Amylyx Pharmaceuticals 股价盘前上涨 ~4.5% 至 16 美元** 公司报告第四季度营收为 1.084 亿美元, (link),去年同期为 2190 万美元。** 收入的同比增长主要得益于对公司肌萎缩性脊髓侧索硬化症(ALS) 药物 Relyvrio 的强劲需求。** ALS 是一种罕见的神经系统疾病,会破坏大脑和脊髓中负责肌肉运动的神经细胞。** 截至上次收盘,股价在过去 12 个月中下跌了 57","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amylyx.com","stockEarnings":[{"period":"1week","weight":-0.0303},{"period":"1month","weight":-0.836},{"period":"3month","weight":-0.8047},{"period":"6month","weight":-0.8427},{"period":"1year","weight":-0.9056},{"period":"ytd","weight":-0.8043}],"compareEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":0.034},{"period":"3month","weight":0.0975},{"period":"6month","weight":0.2238},{"period":"1year","weight":0.3225},{"period":"ytd","weight":0.1007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Amylyx Pharmaceuticals, Inc.于2014年1月10日根据特拉华州法律成立。他们的任务是开发治疗方法,通过让神经元存活来改变肌萎缩侧索硬化症和一系列神经退行性疾病的治疗模式。该公司正在寻求其候选产品AMX0035的商业化,他们认为这是第一个在ALS患者的大规模临床试验中显示出功能和生存益处的候选药物。该公司相信AMX0035有潜力成为一种基础疗法,这意味着它可以单独使用或与其他疗法结合使用,以改变广泛的神经退行性疾病的治疗模式。","exchange":"NASDAQ","name":"Amylyx Pharmaceuticals, Inc.","nameEN":"Amylyx Pharmaceuticals, Inc."},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amylyx Pharmaceuticals, Inc.(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Amylyx Pharmaceuticals, Inc.(AMLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Amylyx Pharmaceuticals, Inc.,AMLX,Amylyx Pharmaceuticals, Inc.股票,Amylyx Pharmaceuticals, Inc.股票老虎,Amylyx Pharmaceuticals, Inc.股票老虎国际,Amylyx Pharmaceuticals, Inc.行情,Amylyx Pharmaceuticals, Inc.股票行情,Amylyx Pharmaceuticals, Inc.股价,Amylyx Pharmaceuticals, Inc.股市,Amylyx Pharmaceuticals, Inc.股票价格,Amylyx Pharmaceuticals, Inc.股票交易,Amylyx Pharmaceuticals, Inc.股票购买,Amylyx Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amylyx Pharmaceuticals, Inc.(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Amylyx Pharmaceuticals, Inc.(AMLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}